Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency
Stock Information for Jaguar Health Inc.
Loading
Please wait while we load your information from QuoteMedia.